MULLER-TRUTWIN; Michaela

Patent Applications and Registrations

Patent applications and USPTO patent grants for MULLER-TRUTWIN; Michaela.The latest application filed is for "treatments to eliminate hiv reservoirs and reduce viral load".

Company Profile

0.7.8

MULLER-TRUTWIN; Michaela - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatments To Eliminate Hiv Reservoirs And Reduce Viral Load App 20210010094 - HUOT; Nicolas ; et al.	2021-01-14
Treatments to eliminate HIV reservoirs and reduce viral load Grant 10,815,540 - Huot , et al. October 27, 2	2020-10-27
Treatments To Eliminate Hiv Reservoirs And Reduce Viral Load App 20190218628 - HUOT; Nicolas ; et al.	2019-07-18
Treatments to eliminate HIV reservoirs and reduce viral load Grant 10,323,289 - Huot , et al.	2019-06-18
Levels of CXCL10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS Grant 10,254,282 - Muller-Trutwin , et al.	2019-04-09
Treatments To Eliminate Hiv Reservoirs And Reduce Viral Load App 20180371556 - HUOT; Nicolas ; et al.	2018-12-27
Levels Of Cxcl10/ip-10 Forms And Soluble Cd26/dppiv Activity As Early Predictive Biomarkers For Hiv/siv Associated Mucosal Inflammation And Progression Towards Aids App 20170269084 - MULLER-TRUTWIN; Michaela ; et al.	2017-09-21
Levels of CXCL 10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS Grant 9,523,687 - Muller-Trutwin , et al. December 20, 2	2016-12-20
Levels Of Cxcl 10/ip-10 Forms And Soluble Cd26/dppiv Activity As Early Predictive Biomarkers For Hiv/siv Associated Mucosal Inflammation And Progression Towards Aids App 20150247853 - MULLER-TRUTWIN; Michaela ; et al.	2015-09-03
Method for identifying motifs and/or combinations of motifs having a boolean state of predetermined mutation in a set of sequences and its application Grant 8,032,309 - Vanet , et al. October 4, 2	2011-10-04
Method for identifying combinations of motifs that do not mutate simultaneously in a set of viral polypeptide sequences comprising a putative drug binding site Grant 7,917,303 - Vanet , et al. March 29, 2	2011-03-29
Method For Identifying Motifs And/or Combinations Of Motifs Having A Boolean State Of Predetermined Mutation In A Set Of Sequences And Its Application App 20100183670 - Vanet; Anne ; et al.	2010-07-22
Method for identifying motifs and/or combinations of motifs having a boolean state of predetermined mutation in a set of sequences and its applications Grant 7,734,421 - Vanet , et al. June 8, 2	2010-06-08
Method for identifying motifs and/or combinations of motifs having a boolean state of predetermined mutation in a set of sequences and its applications App 20070020619 - Vanet; Anne ; et al.	2007-01-25
Method for identifying motifs and/or combinations of motifs having a boolean state of predetermined mutation in a set of sequences and its applications App 20040203028 - Vanet, Anne ; et al.	2004-10-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.